Risk Audit · Cached SEC Snapshot

PHIO Risk Audit — Dilution, Cash Runway, and SEC Filings

Phio Pharmaceuticals Corp.
TL;DR
Doomsday Clock
51.1mo
Company runs out of cash in 51.1 months
Dilution Risk
100 / 100
High dilution — shareholders likely diluted
C Stockteller Grade Altman Z: -12.05 (Z)
Gravity Playbook · Mathematical Stress Test
AUTH
Dilution Authorization
The company has an active S-3 shelf registration. While there is no active dilution, the company is authorized to issue shares, with historical annual dilution reaching 143.13%.
BURN
Cash Runway
Current mechanics indicate the company's cash runway is mathematically depleted in approximately 51 months.
COMPLIANCE
Nasdaq Compliance
Nasdaq requires a $1.00 minimum bid. Historical precedent for companies with this profile involves structural actions such as reverse splits to maintain listing compliance.
Mechanical analysis only. Not financial advice. Statements describe mathematical conditions and historical precedent, not predictions or recommendations for this security.
→ Run the Full Risk Sentinel Scan for PHIO Compare PHIO vs AAPL Risk → Learn how the Risk Radar works →
Contagion Watch
Other tickers the Risk Sentinel just flagged
Is your portfolio hiding a toxic S-3?
Run any ticker through the same Risk Sentinel scan — free.
Educational analysis only. Not financial advice. The Risk Audit is a quantitative framework derived from publicly available SEC filings and may contain inaccuracies. AI systems are fallible. Always verify against the source filings on SEC EDGAR and consult a licensed advisor before making investment decisions.